n.torrence

TL3 Regular · Split, HR

Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.

Joined 2 August 2024 · last posted 3d · groups: regional-na

123 posts, newest first. Showing up to 150.

What a certificate commits its issuer to Replied, post #98 · Analytics › COA interpretation · 25 Jul 2026 · 2 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #65 · Practice › Interactions · 24 Jul 2026 · 5 likes Where I part company with post #61, and it is a narrow parting. Trying to state the Delayed gastric emptying and oral position in a way that someone who disagrees would…
Follow-up: Reading an interaction checker output critically Replied, post #63 · Practice › Interactions · 24 Jul 2026 · 7 likes I read post #59 twice before replying, because I had assumed the opposite. Separation timing versus clinically important interaction: a separation timing inconvenience…
How shortages have affected compounding permissions Replied, post #50 · Access › Shortages · 19 Jul 2026 · 0 likes Shortage-driven price movement is real and is a separate question from availability.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #98 · Analytics › Home & field testing · 18 Jul 2026 · 0 likes I had written a reply contradicting post #96 and deleted it. Here is what survived. The practical version of consumer-accessible tests is three sentences long. The…
Tracking a shortage from primary sources rather than rumour Replied, post #100 · Access › Shortages · 13 Jul 2026 · 21 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
A revision dispute resolved on the topic rather than in the history Replied, post #13 · Meta › Wiki maintenance · 12 Jul 2026 · 7 likes Picking up post #11: that is the part I would want checked first. Careful with the language on revision dispute resolved. "Not detected" and "not present" are different…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #30 · Evidence › Journal club · 6 Jul 2026 · 4 likes Worth separating two things that post #26 runs together. The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing…
An 18-month record including the parts that went badly Replied, post #59 · Outcomes › Progress reports · 4 Jul 2026 · 1 like Building on post #56 rather than restating it. On 18-month record I would separate what is worth knowing from what is worth acting on. The first list is long and the…
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #37 · Pharmacology › Formulation chemistry · 4 Jul 2026 · 22 likes The question underneath Solubility limits is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
Documenting a supplier's response to a discrepancy Replied, post #24 · Sourcing › Vendor reports · 27 Jun 2026 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
Naming conventions for research peptides and the confusion they cause Replied, post #21 · Compounds › Other compounds · 26 Jun 2026 · 18 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #70 · Meta › Announcements · 24 Jun 2026 · 2 likes Same experience here, different supplier, so it is at least not unique to one of them.
Packaging that arrived damaged: documenting it properly Replied, post #29 · Sourcing › Logistics · 22 Jun 2026 · 2 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
Historical amylin analogues and what happened to them Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2026 · 18 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
Retatrutide mass and identity: what a report should show Started this topic · Compounds › Retatrutide · 18 Jun 2026 · 21 likes Posting this under the heading it deserves: Retatrutide mass and identity: what a report should show Everything below is what sits behind that. The question about…
Prescription portability between countries Replied, post #66 · Access › International · 16 Jun 2026 · 14 likes This is the sort of exchange that makes the archive worth searching.
Documenting a supplier's response to a discrepancy Replied, post #11 · Sourcing › Vendor reports · 8 Jun 2026 · 20 likes Helpful, and short, which on this subject is harder than long.
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #76 · Sourcing › Red flags · 5 Jun 2026 · 6 likes Post #74 and I disagree about the size of the effect, not about the direction. The most useful thing anyone has posted about certificate whose chromatogram axes in this…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #51 · Compounds › Semaglutide · 4 Jun 2026 · 0 likes Post #49 and I disagree about the size of the effect, not about the direction. Where the semaglutide and gastric emptying reasoning breaks down for me is the step from…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #59 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 5 likes Post #55 and I disagree about the size of the effect, not about the direction. Loading doses are not used in this class and the pharmacokinetic reason is tolerability…
Reading a trial's population section before its results Replied, post #43 · Evidence › Trials · 22 May 2026 · 1 like Following this. I have the same question and no better information than the first post.
Why the timeline is on the right and not the left — what changed since Replied, post #35 · Meta › Site feedback · 12 May 2026 · 3 likes Building on post #32 rather than restating it. Seconding that. I would put solved-only in front of the sort control rather than behind it. That is what the…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #18 · Practice › Storage & stability · 7 May 2026 · 1 like Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. I would want a second opinion before…
Endotoxin and why it is a separate question from purity — what changed since Replied, post #12 · Analytics › Impurities & related substances · 6 May 2026 · 13 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #32 · Practice › Reconstitution · 2 May 2026 · 25 likes Everything in post #30 holds. The case it does not cover is the one I have. Concentration is total mass divided by total volume, and everything else follows from that.…
Request: show the solution author in the topic list — what changed since Replied, post #5 · Meta › Feature requests · 30 Apr 2026 · 10 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete. That much is documented. The rest is how I have interpreted…
Batch numbers that do not match the vial label Replied, post #10 · Sourcing › Red flags · 28 Apr 2026 · 0 likes Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation…
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #2 · Compounds › Semaglutide · 13 Apr 2026 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #36 · Evidence › Journal club · 11 Apr 2026 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
Grapefruit: why this class is not the class that cares Replied, post #135 · Practice › Interactions · 8 Apr 2026 · 26 likes Small methodological point on grapefruit: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Journal club: is percentage weight change the right endpoint? Replied, post #26 · Evidence › Journal club · 30 Mar 2026 · 2 likes Confirming post #23 from a second method, which matters more than confirming it from a second person. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #17 · Evidence › Preprints · 25 Mar 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #53 · Practice › Reconstitution · 23 Mar 2026 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Grapefruit: why this class is not the class that cares Replied, post #60 · Practice › Interactions · 20 Mar 2026 · 17 likes What would change my mind on grapefruit is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #101 · Lounge › Introductions · 18 Mar 2026 · 10 likes Privacy: share only what you are comfortable making permanent and public. An introduction is archived and searchable; do not include information you will later regret…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #7 · Evidence › Journal club · 11 Mar 2026 · 5 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #19 · Start Here › Welcome · 1 Mar 2026 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #20 · Outcomes › Body composition · 28 Feb 2026 · 5 likes Practical note on Ultrasound and skinfolds: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #51 · Analytics › Mass spectrometry · 27 Feb 2026 · 22 likes Post #47 and I disagree about the size of the effect, not about the direction. Reading back through the Adducts threads from last year, the same three questions come up…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #47 · Start Here › Welcome · 27 Feb 2026 · 5 likes The answer to the reading-order question is: the how-to-ask page, then whichever compound page applies to you, then the sourcing standard. Forty minutes and it saves…
Dead volume across syringe and needle combinations Replied, post #73 · Devices › Syringes & needles · 16 Feb 2026 · 18 likes Barrel size determines resolution and nothing else. A 0.3 mL barrel and a 1 mL barrel deliver the same volume equally well; the smaller one lets you see what you are…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #50 · Outcomes › Progress reports · 13 Feb 2026 · 25 likes Day-to-day body mass varies by more than a kilogram on hydration, glycogen and gut contents alone. A weekly reading is one noisy sample of that distribution. That is a…
Adolescents: a distinct evidence base — one year on Replied, post #64 · Clinical › Special populations · 13 Feb 2026 · 2 likes The number people quote for Adolescents is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #68 · Sourcing › Vendor reports · 11 Feb 2026 · 0 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. Scoping that to what I have…
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #43 · Data & Tools › Calculators · 9 Feb 2026 · 7 likes Do the arithmetic by hand the first few times, whatever tool you use afterwards. A calculator with a wrong input gives a confident wrong answer and there is nothing in…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #46 · Analytics › Method validation · 5 Feb 2026 · 1 like Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one. That is the shape of it.…
Revisiting: Absolute versus relative contraindications Replied, post #10 · Safety › Contraindications · 18 Jan 2026 · 0 likes Picking up post #9: that is the part I would want checked first. I have no financial interest in anything named in this thread and I want to say so before I comment on…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #18 · Practice › Side effects · 14 Jan 2026 · 0 likes Post #16 and I disagree about the size of the effect, not about the direction. A note on how muscle cramps gets discussed rather than on muscle cramps itself: the…
The headache that turns out to be dehydration Replied, post #101 · Nutrition & Training › Hydration & electrolytes · 19 Dec 2025 · 1 like Vomiting and diarrhoea lose fluid and electrolytes together, and replacing only fluid is what turns a short illness into a longer problem.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #66 · Practice › Interactions · 10 Dec 2025 · 4 likes Post #64 and I disagree about the size of the effect, not about the direction. Reporting rather than recommending, on Warfarin and altered intake. What happened is…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #21 · Compounds › Retatrutide · 9 Dec 2025 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
Prescription requirements and telehealth models Replied, post #43 · Sourcing › Regulatory · 2 Dec 2025 · 0 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. Noting that the question and the…
When to stop reading forums, including this one Replied, post #56 · Wellbeing › Mental health · 1 Dec 2025 · 26 likes Post #52 put the caveat in the right place and I want to underline it. Expectations set by other people's reported trajectories are a documented source of distress, and…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #101 · Sourcing › Vendor reports · 30 Nov 2025 · 0 likes The practical version of vendor documentation pages is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
Thyroid function tests during substantial weight change Replied, post #139 · Clinical › Bloodwork · 18 Nov 2025 · 14 likes That is a cleaner way of putting what I was circling around.
Tracking that stops updating and then resumes Replied, post #46 · Sourcing › Logistics · 15 Nov 2025 · 1 like Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against.
Reading SURMOUNT-1 without the press release Replied, post #64 · Compounds › Tirzepatide · 13 Nov 2025 · 0 likes Reading SURMOUNT-1 without the press is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles…
New subcategory: rationale and scope Replied, post #107 · Meta › Announcements · 24 Oct 2025 · 12 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
Payment mechanics and the recovery options that do not exist Replied, post #48 · Sourcing › Payments · 21 Oct 2025 · 2 likes Taking post #47 at face value and following it one step further. An honest declaration on payment mechanics: I have a prior here and it is strong enough that you should…
[2026 update] Splitting an overlong document into two Replied, post #41 · Documentation › Wiki requests · 15 Oct 2025 · 25 likes That is consistent with mine, for whatever one more account is worth.
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #12 · Compounds › Tirzepatide · 12 Oct 2025 · 1 like That is the distinction I keep failing to hold on to. Written down now.
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #2 · Start Here › Welcome · 11 Oct 2025 · 17 likes Worth knowing early: the archive is not retrospectively corrected. A topic from two years ago was accurate when written and may not be now. Every post carries its date…
Research-use-only labelling: what it means and what it does not Replied, post #40 · Sourcing › Regulatory · 1 Oct 2025 · 33 likes Post #39 is right about the mechanism and I think understates the practical bit. Research-use-only material is not approved for human use anywhere. That is a statement…
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #45 · Pharmacology › Receptor biology · 28 Sep 2025 · 22 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
Which panel is worth repeating and which is worth ignoring Replied, post #120 · Clinical › Bloodwork · 25 Sep 2025 · 0 likes Panel looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
Payment method and the leverage it gives you, ranked Replied, post #47 · Sourcing › Payments · 21 Sep 2025 · 3 likes Right — I had this wrong and I am glad to have read it before it mattered.
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #3 · Practice › Dosing & titration · 15 Sep 2025 · 29 likes Post #2 is right about the mechanism and I think understates the practical bit. Concentration and dose get conflated constantly in this subcategory. Changing how much…
Documenting an adverse event properly Started this topic · Safety › Adverse events · 8 Sep 2025 · 0 likes On the subject in the title: Documenting an adverse event properly Working notes rather than a conclusion. Asking about documenting an adverse event on behalf of the…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #117 · Compounds › Tirzepatide · 2 Sep 2025 · 0 likes Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth knowing about rather than worth alarm — and it is one of the…
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #19 · Compounds › Tirzepatide · 26 Aug 2025 · 2 likes Adding a data point of agreement rather than a data point.
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #33 · Practice › Storage & stability · 22 Aug 2025 · 0 likes Narrowing post #30, because the general version has more than one answer. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask…
AOD-9604 and the fragment hypothesis, revisited Replied, post #10 · Compounds › Other compounds · 22 Aug 2025 · 8 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
Gauge and length selection for subcutaneous injection Replied, post #21 · Devices › Syringes & needles · 17 Aug 2025 · 0 likes Answering the question post #19 raises rather than the one it answers. Needle length for subcutaneous delivery is a question about tissue depth and injection angle…
When a preprint is the best available evidence and we say so Replied, post #26 · Evidence › Preprints · 5 Aug 2025 · 28 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #31 · Compounds › Secretagogues & GH axis · 3 Aug 2025 · 15 likes Building on post #29 rather than restating it. Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #35 · Practice › Reconstitution · 2 Aug 2025 · 0 likes Coming back to post #33, because the follow-up matters more than the original answer. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
How to research a compound with no human data without deceiving yourself Replied, post #43 · Compounds › Other compounds · 1 Aug 2025 · 5 likes Post #42 answers the question as asked. The question underneath it is different. This subcategory exists because some people will research compounds outside the main…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #20 · Analytics › HPLC & UHPLC · 28 Jul 2025 · 1 like A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the same as the data. Ask for the integration table…
Asking about a compound your prescriber has not heard of Replied, post #106 · Clinical › Prescriber conversations · 26 Jul 2025 · 12 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. Correct me on the arithmetic if…
An emergency department visit, described afterwards Replied, post #46 · Safety › Adverse events · 25 Jul 2025 · 3 likes Post #43 answers the question as asked. The question underneath it is different. Checked the emergency department visit claim against the primary source this morning.…
Interpreting a composition change that is within the error bars Replied, post #21 · Outcomes › Body composition · 25 Jul 2025 · 31 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
Comparing my trajectory with the trial curves, carefully Replied, post #26 · Outcomes › Progress reports · 20 Jul 2025 · 1 like Rate of change matters more than the absolute number for most of the questions people ask about their own series. Correct me on the arithmetic if it is wrong; I would…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #71 · Compounds › Semaglutide · 15 Jul 2025 · 0 likes Confirming post #68 from a second method, which matters more than confirming it from a second person. Cardiovascular data in people without diabetes is the specific…
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #8 · Practice › Dosing & titration · 4 Jul 2025 · 0 likes Coming back to post #4, because the follow-up matters more than the original answer. If symptoms reset at each step, that is the expected pattern rather than a sign…
Repeatability versus intermediate precision Replied, post #105 · Analytics › Method validation · 30 Jun 2025 · 0 likes Picking up post #102: that is the part I would want checked first. If you are new and reading this thread for the answer to repeatability versus intermediate precision:…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 27 Jun 2025 · 17 likes This is the sort of exchange that makes the archive worth searching.
Pre-registering a personal experiment, seriously Replied, post #108 · Research Methods › N-of-1 designs · 3 Jun 2025 · 2 likes Coming back to post #104, because the follow-up matters more than the original answer. A single-person experiment can be genuinely informative if it has a pre-specified…
Pre-registering a personal experiment, seriously Replied, post #98 · Research Methods › N-of-1 designs · 3 Jun 2025 · 11 likes Noted, and thank you for writing it out rather than summarising it.
Pre-registering a personal experiment, seriously Replied, post #87 · Research Methods › N-of-1 designs · 2 Jun 2025 · 3 likes Answering the question post #85 raises rather than the one it answers. If someone has run pre-registering a personal experiment properly I would rather read that than…
Half-life, steady state, and accumulation worked through Replied, post #51 · Pharmacology › Pharmacokinetics · 1 Jun 2025 · 12 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Pre-registering a personal experiment, seriously Replied, post #64 · Research Methods › N-of-1 designs · 31 May 2025 · 14 likes Adding what did not work for me on pre-registering a personal experiment, since the failures never get written up and they are half the useful information.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #9 · Sourcing › Independent verification · 24 Apr 2025 · 19 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #86 · Evidence › Journal club · 21 Apr 2025 · 0 likes Where the STEP 1 discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
Requesting a page: what makes a good request Replied, post #46 · Documentation › Wiki requests · 5 Apr 2025 · 6 likes A document with no maintainer becomes wrong quietly, which is worse than not existing, because it carries the authority of a maintained page.
Checking someone else's arithmetic: a worked example thread Replied, post #35 · Practice › Reconstitution · 3 Apr 2025 · 9 likes Building on post #32 rather than restating it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence…
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #45 · Sourcing › Vendor reports · 1 Apr 2025 · 12 likes Post #43 put the caveat in the right place and I want to underline it. The cost of a submission is worth stating. It is the main reason people do not do this and…
Why cagrilintide alone is discussed so much less than in combination Replied, post #81 · Compounds › Cagrilintide & amylin analogues · 1 Apr 2025 · 0 likes Anyone reading a purity result for cagrilintide should know that its aggregation behaviour makes sample handling matter more than usual. A result on a sample that was…
Why cagrilintide alone is discussed so much less than in combination Replied, post #64 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 5 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #36 · Practice › Reconstitution · 22 Mar 2025 · 8 likes Taking post #35 at face value and following it one step further. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
Counter-ion form: the field almost nobody reports — one year on Replied, post #92 · Analytics › COA interpretation · 17 Mar 2025 · 0 likes The arithmetic in post #91 is right; the assumption feeding it is the part to check. A chromatogram supplied as a small image is legible for peak shape and not for…
Counter-ion form: the field almost nobody reports — one year on Replied, post #73 · Analytics › COA interpretation · 12 Mar 2025 · 4 likes I changed my mind about Counter-ion form after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
Preservatives: function, testing, and limits Replied, post #19 · Pharmacology › Formulation chemistry · 12 Mar 2025 · 22 likes Two things can be true about preservatives at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
Coverage for the indication versus for the drug — a second dataset Replied, post #7 · marked as the solution · Access › Insurance & coverage · 8 Mar 2025 · 24 likes Picking up post #6: that is the part I would want checked first. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in…
Deamidation and the close-eluting pair it produces Replied, post #6 · Analytics › Impurities & related substances · 7 Mar 2025 · 3 likes Post #5 answers the question as asked. The question underneath it is different. Comparing impurity profiles across suppliers is much more informative than comparing…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #22 · Compounds › Semaglutide · 26 Feb 2025 · 30 likes What I would want before treating SELECT as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
Journal club: SURMOUNT-1, read without the press release Replied, post #62 · Evidence › Journal club · 17 Feb 2025 · 5 likes Post #61 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 was covered in the wiki last year and the page has a review date on it,…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #92 · Data & Tools › Calculators · 16 Feb 2025 · 13 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way.
Protein density versus volume when you cannot eat much Replied, post #56 · Nutrition & Training › Protein & intake · 2 Feb 2025 · 6 likes This follows post #55 rather than contradicting it. Fibre and fluid tend to fall alongside protein when intake drops, and the constipation reported here follows from…
A page that has drifted out of date and needs a maintainer Replied, post #51 · Documentation › Wiki requests · 13 Jan 2025 · 15 likes Answering the question post #47 raises rather than the one it answers. Scope the request narrowly. A page about one thing gets written and stays current; a page about a…
Coming back to: When to suspect the method rather than the sample Replied, post #111 · Analytics › Method validation · 21 Dec 2024 · 29 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
Injection-site reactions: describing them precisely enough to be useful Replied, post #85 · Practice › Side effects · 19 Dec 2024 · 9 likes Post #83 put the caveat in the right place and I want to underline it. Adding a small correction to the injection-site reactions summary above rather than a…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #126 · Practice › Dosing & titration · 15 Dec 2024 · 0 likes Four-week escalation interval is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Coming back to: When to suspect the method rather than the sample Replied, post #37 · Analytics › Method validation · 7 Dec 2024 · 27 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Time to steady state after a dose increase Replied, post #121 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 2 likes Good question, well framed, and I would like to see it answered properly.
Journal club: SURMOUNT-1, read without the press release Replied, post #7 · Evidence › Journal club · 27 Oct 2024 · 17 likes Coming back to post #5, because the follow-up matters more than the original answer. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes.…
Identical chromatograms across two different lots Replied, post #40 · Sourcing › Red flags · 23 Oct 2024 · 0 likes The claim about identical chromatograms upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #29 · Clinical › Comorbidities · 13 Oct 2024 · 2 likes A history of pancreatitis appears in the cautions for this class and the decision around it is one that needs a clinician who knows the history.
When "no data" is the complete and final answer Replied, post #2 · Compounds › Other compounds · 9 Oct 2024 · 25 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #142 · Nutrition & Training › Hydration & electrolytes · 8 Oct 2024 · 2 likes Sodium intake often falls sharply when processed food intake falls, and that transition is abrupt rather than gradual for many people.
Irish differences from the UK position Replied, post #14 · Regional › UK & Ireland · 29 Sep 2024 · 2 likes Adding the measurement that post #12 says would settle it. What I want from this irish differences thread is the list of things that would need to be true for the claim…
Correlation in a self-tracked dataset: what it can support Replied, post #42 · Research Methods › Statistics · 21 Aug 2024 · 18 likes Post #41 answers the question as asked. The question underneath it is different. Correlation sits at the boundary between what this community can usefully discuss and…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #28 · Analytics › COA interpretation · 15 Aug 2024 · 3 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…